Jaguar Health (JAGX) Receivables - Other (2015 - 2026)
Jaguar Health's (JAGX) quarterly Receivables - Other came in at $212000.0 in Q1 2026, up 27.71% year-on-year from $166000.0 in Q1 2025, and up 96.3% on a QoQ basis from $108000.0 in Q4 2025.
Jaguar Health (JAGX) Receivables - Other (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Receivables - Other data on file, last reported at $212000.0 in Q1 2026.
- On a quarterly basis, Receivables - Other rose 27.71% year-over-year to $212000.0 in Q1 2026; TTM through Mar 2026 was $212000.0, a 27.71% increase from a year earlier, with the FY2025 full-year figure at $177000.0, up 47.5% from the prior year.
- Receivables - Other for Q1 2026 stood at $212000.0, up from $108000.0 in the prior quarter.
- Over the last five years, Receivables - Other for JAGX reached as high as $634000.0 in Q3 2022 and fell as low as -$85000.0 in Q4 2022.
- Historically, Receivables - Other has averaged $202882.4 across 5 years, with a median of $161000.0 in 2023.
- On a YoY basis, Receivables - Other climbed as much as 1433.33% in 2022 and fell as far as 124.93% in 2022.
- Year by year, Receivables - Other stood at -$85000.0 in 2022, then jumped by 136.47% to $31000.0 in 2023, then soared by 138.71% to $74000.0 in 2024, then surged by 45.95% to $108000.0 in 2025, then soared by 96.3% to $212000.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $212000.0 in Q1 2026, $108000.0 in Q4 2025, and $67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,000.00 |
| Mar 31, 2026 | 212,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Dec 31, 2025 | 108,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Jun 30, 2025 | 143,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |